Jonathan Mathers

Jonathan Mathers i

University of Birmingham - Birmingham / United Kingdom
Others
AD Scientific Index ID: 4322181
person_outline Jonathan Mathers's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 2021786*2021
2-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...Medrxiv, 2021.06. 15.21258542, 2021434*2021
3-) Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative GroupLancet (London, England) 399 (10320), 143, 20222442022
4-) The use of qualitative methods to inform Delphi surveys in core outcome set developmentT Keeley, P Williamson, P Callery, LL Jones, J Mathers, J Jones, B Young, ...Trials 17, 1-9, 20162012016
5-) Use of health impact assessment in incorporating health considerations in decision makingC Davenport, J Mathers, J ParryJournal of Epidemiology & Community Health 60 (3), 196-201, 20061652006
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.   Cookie Policy